XML 31 R15.htm IDEA: XBRL DOCUMENT

Note 7 - Supplemental Balance Sheets Information

12 Months Ended

Mar. 31, 2022

Note 7. Supplemental Balance Sheets Information

Accrued payroll and benefits consisted of the following:

	*March 31, 2022*		*March 31, 2021*
Bonus payable	$	7,468	$	3,504
Wages and paid-time-off payable		3,677		3,562
Payroll related taxes		2,069		2,043
Other benefits payable		1,503		279
Total accrued payroll and benefits	$	14,717	$	9,388

Other accrued expenses consisted of the following:

	*March 31, 2022*		*March 31, 2021*
Accrued business taxes	$	4,967	$	4,749
Current operating lease liabilities		2,768		1,023
Customer deposits		751		514
Income taxes payable		928		1,648
Other		2,197		2,011
Total other accrued expenses	$	11,611	$	9,945

Property, plant and equipment consisted of the following:

	*March 31, 2022*			*March 31, 2021*
Land	$	889		$	889
Buildings		21,537			18,857
Manufacturing equipment		17,336			12,163
Computer equipment		4,519			4,350
Construction in progress		487			985
Other		1,578			1,084
Gross total		46,346			38,328
Accumulated depreciation		(17,726	)		(16,330	)
Property, plant and equipment, net	$	28,620		$	21,998

Depreciation expense for the years ended March 31, 2022, 2021 and 2020 was $3,262, $2,959, and $2,234, respectively.

Inventories consisted of the following:

As of March 31, 2022, $11,802 of total inventory on hand is attributable to the new Clinical Genomics division.